Exelixis, Inc. (EXEL): Price and Financial Metrics
Exelixis, Inc. (EXEL)
Today's Latest Price: $17.82 USD
0.17 (0.96%)
Updated Dec 13 6:55pm
Add EXEL to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
EXEL Stock Summary
- With a price/earnings ratio of 7.98, Exelixis Inc P/E ratio is greater than that of about only 10.07% of stocks in our set with positive earnings.
- For EXEL, its debt to operating expenses ratio is greater than that reported by just 11.58% of US equities we're observing.
- Equity multiplier, or assets relative to shareholders' equity, comes in at 1.11 for Exelixis Inc; that's greater than it is for only 8.07% of US stocks.
- Stocks that are quantitatively similar to EXEL, based on their financial statements, market capitalization, and price volatility, are PTN, ACIA, SLAB, NVMI, and MEET.
- Visit EXEL's SEC page to see the company's official filings. To visit the company's web site, go to www.exelixis.com.
EXEL Daily Price Range
EXEL 52-Week Price Range
EXEL Stock Price Chart More Charts
EXEL Price/Volume Stats
| Current price | $17.82 | 52-week high | $25.31 |
| Prev. close | $17.65 | 52-week low | $15.02 |
| Day low | $17.68 | Volume | 3,079,200 |
| Day high | $18.32 | Avg. volume | 3,073,385 |
| 50-day MA | $16.61 | Dividend yield | N/A |
| 200-day MA | $19.87 | Market Cap | 5.41B |
Exelixis, Inc. (EXEL) Company Bio
Exelixis is a biopharmaceutical company committed to developing small molecule therapies for the treatment of cancer. The company was founded in 1994 and is based in San Francisco, California.
Top Stories View All
3 “Must Own” Online Growth Stocks
Best & Worst Performing Stock Industries for December 13, 2019
Best & Worst Performing Small Cap Stocks for December 13, 2019
Best & Worst Performing Mid Cap Stocks for December 13, 2019
Best & Worst Performing Large Cap Stocks for December 13, 2019
View All Top Stories
Loading social stream, please wait...